PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate: a Facility-Level Cost-Offset Model Under the Medicare Bundle

Saved in:
Bibliographic Details
Published inValue in health Vol. 15; no. 4; p. A155
Main Authors Mutell, R, Rubin, J.L, Bond, T.C, Mayne, T
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.06.2012
Subjects
Internal Medicine
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2012.03.836